A prospective cohort study protocol on sequential compression alone for the prevention of venous thromboembolism (VTE) in laparoscopic cholecystectomy
Prospektives Kohortenstudienprotokoll zu sequenzieller Kompression allein zur Prävention venöser Thromboembolien (VTE) bei laparoskopischer Cholezystektomie
International Journal of Surgery Protocols · 2026-09 · 30 (3) · 33-37
DOI: 10.1097/sp9.0000000000000068 ↗Auf einen Blick
Geplant ist eine multizentrische prospektive Kohortenstudie zu SCCDs allein bei laparoskopischer Cholezystektomie. Untersucht werden klinische VTE 30 Tage nach der Operation sowie Blutungen und weitere Komplikationen.
Fragestellung
Wie häufig treten klinische VTE 30 Tage nach laparoskopischer Cholezystektomie unter alleiniger intraoperativer Anwendung von SCCDs auf?
Methode
Multizentrische, einarmige, prospektive Kohortenstudie in 11 Krankenhäusern; Rekrutierung von 5190 Patient:innen; 30-Tage-Befragung und radiologische Bestätigung bei Symptomen.
Ergebnisse
Geplante Rekrutierung von 5190 Patient:innen in 11 Krankenhäusern. Primärer Endpunkt ist die Inzidenz klinischer VTE 30 Tage nach der Operation; sekundär werden Blutungen und andere Komplikationen erfasst.
Einschränkungen
Einarmiges Protokoll; Vergleich mit historischen Kontrollen.
Schlussfolgerung der Autor:innen
Die Studie soll Informationen zur VTE-Inzidenz nach Einsatz von SCCDs allein liefern und diese mit historischen Kontrollen vergleichen. Genannt werden wirtschaftliche, sicherheitsbezogene und ökologische Verbesserungen.
Kernaussagen
- SCCDs allein bei laparoskopischer Cholezystektomie
- Primär: klinische VTE 30 Tage nach OP
- Sekundär: Blutungen und andere Komplikationen
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Kohortenstudie in der Zeitschrift International Journal of Surgery Protocols, online erschienen am 27.07.2026. Verfasst von Chien-Tse Kao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Surgery, Northern Health, Epping, Australia. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
Background
Venous thromboembolism (VTE) is one of the leading causes of in-hospital mortality and is responsible for significant healthcare-related costs. However, a clear thromboprophylaxis protocol does not exist in surgery. The conventional method of thromboprophylaxis in surgery includes a combination of chemical and mechanical measures. Studies have shown that the administration of a chemical prophylaxis agent intra-operatively is associated with an increased incidence of surgical bleeding in surgeries such as laparoscopic cholecystectomy (LC). There are two common forms of mechanical prophylaxis: graduated compression stockings (GCSs) and sequential calf compression devices (SCCDs). Recent evidence has suggested several unwanted effects of GCSs, including skin breakage, the development of ulcers, and necrosis. There is a paucity of evidence investigating the use of SCCDs alone intra-operatively in VTE and surgical bleeding prevention. Materials and methods: This study reports on a multi-center, single-arm, prospective cohort study conducted across 11 hospitals, focusing on LC to standardize the operation. The aim is to recruit 5190 patients, as determined by power calculations, to investigate the incidence of clinical VTE 30 days after surgery. The hospitals involved already have policies in place to use SCCDs alone. All patients undergoing LC will be recruited prospectively, with a 30-day survey conducted to ascertain symptoms of VTE. Any reported symptoms will prompt appropriate radiological confirmation. The secondary outcome of bleeding or other complications arising from VTE prophylaxis will also be collected.
Results
Ethical approval was obtained for this study. Results will be submitted for publication in a peer-reviewed journal and disseminated through participating hospitals.
Conclusion
This study aims to provide information on the incidence of VTE in the LC population following the use of SCCDs only at the time of surgery and to compare it to historical controls of combined SCCDs and GCSs. The benefits include economic, safety, and environmental improvements.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Surgery, Northern Health, Epping, Australia.
- Department of Anaesthesia & Perioperative Medicine, Northern Health, Epping, Australia.
- Department of Critical Care, Melbourne Medical School, The University of Melbourne, Parkville, Australia.
- Department of Intensive Care, Northern Health, Epping, Australia.
- Department of Research, Northern Health, Epping, Australia.
- Department of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, Australia.
ORCID-Profile: Darren Lowen, Justin M Yeung, Russell Hodgson
Zitieren
APA
Kao, C. T., Lowen, D., Said, S., Tacey, M., Taylor, D., Yeung, J. M., & Hodgson, R. (2026). A prospective cohort study protocol on sequential compression alone for the prevention of venous thromboembolism (VTE) in laparoscopic cholecystectomy. International Journal of Surgery Protocols, 30(3), 33-37. https://doi.org/10.1097/sp9.0000000000000068
Vancouver
Kao CT, Lowen D, Said S, Tacey M, Taylor D, Yeung JM, et al. A prospective cohort study protocol on sequential compression alone for the prevention of venous thromboembolism (VTE) in laparoscopic cholecystectomy. International Journal of Surgery Protocols. 2026;30(3):33-37. doi:10.1097/sp9.0000000000000068
BibTeX
@article{Kao2026,
author = {Kao, Chien-Tse and Lowen, Darren and Said, Simone and Tacey, Mark and Taylor, Danielle and Yeung, Justin M and Hodgson, Russell},
title = {A prospective cohort study protocol on sequential compression alone for the prevention of venous thromboembolism (VTE) in laparoscopic cholecystectomy},
journal = {International Journal of Surgery Protocols},
year = {2026},
volume = {30},
number = {3},
pages = {33--37},
doi = {10.1097/sp9.0000000000000068}
}
EUVIMED